Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase
- PMID: 27775008
- PMCID: PMC5075776
- DOI: 10.1038/srep35829
Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase
Abstract
The endocannabinoid 2-arachidonoylglycerol (2-AG) mediates retrograde synaptic depression including depolarization-induced suppression of excitation (DSE) and inhibition (DSI). 2-AG is degraded primarily by monoacylglycerol lipase (MAGL), which is expressed in neurons and astrocytes. Using knockout mice in which MAGL is deleted globally or selectively in neurons or astrocytes, we investigated the relative contribution of neuronal and astrocytic MAGL to the termination of DSE and DSI in Purkinje cells (PCs) in cerebellar slices. We report that neuronal MAGL plays a predominant role in terminating DSE at climbing fiber (CF) to PC synapses, while both neuronal and astrocytic MAGL significantly contributes to the termination of DSE at parallel fiber (PF) to PC synapses and DSI at putative Stellate cell to PC synapses. Thus, DSE and DSI at different synapses is not uniformly affected by global and cell type-specific knockout of MAGL. Additionally, MAGL global knockout, but not cell type-specific knockout, caused tonic activation and partial desensitization of the CB1 receptor at PF-PC synapses. This tonic CB1 activation is mediated by 2-AG since it was blocked by the diacylglycerol lipase inhibitor DO34. Together, these results suggest that both neuronal and astrocytic MAGL contribute to 2-AG clearance and prevent CB1 receptor over-stimulation in the cerebellum.
Figures





Similar articles
-
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum.eNeuro. 2016 May 12;3(3):ENEURO.0048-16.2016. doi: 10.1523/ENEURO.0048-16.2016. eCollection 2016 May-Jun. eNeuro. 2016. PMID: 27182552 Free PMC article.
-
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.J Pharmacol Exp Ther. 2009 Nov;331(2):591-7. doi: 10.1124/jpet.109.158162. Epub 2009 Aug 7. J Pharmacol Exp Ther. 2009. PMID: 19666749 Free PMC article.
-
Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum.J Physiol. 2011 Oct 15;589(Pt 20):4847-55. doi: 10.1113/jphysiol.2011.215509. Epub 2011 Sep 12. J Physiol. 2011. PMID: 21911610 Free PMC article.
-
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.Acta Physiol (Oxf). 2012 Feb;204(2):267-76. doi: 10.1111/j.1748-1716.2011.02280.x. Epub 2011 Apr 22. Acta Physiol (Oxf). 2012. PMID: 21418147 Free PMC article. Review.
-
Cerebellar endocannabinoids: retrograde signaling from purkinje cells.Cerebellum. 2015 Jun;14(3):341-53. doi: 10.1007/s12311-014-0629-5. Cerebellum. 2015. PMID: 25520276 Review.
Cited by
-
Long-term depression of presynaptic cannabinoid receptor function at parallel fibre synapses.J Physiol. 2019 Jun;597(12):3167-3181. doi: 10.1113/JP277727. Epub 2019 May 13. J Physiol. 2019. PMID: 31020998 Free PMC article.
-
Meet Your Stress Management Professionals: The Endocannabinoids.Trends Mol Med. 2020 Oct;26(10):953-968. doi: 10.1016/j.molmed.2020.07.002. Epub 2020 Aug 28. Trends Mol Med. 2020. PMID: 32868170 Free PMC article. Review.
-
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS.Int J Mol Sci. 2023 Oct 31;24(21):15829. doi: 10.3390/ijms242115829. Int J Mol Sci. 2023. PMID: 37958825 Free PMC article. Review.
-
Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination.Biomolecules. 2020 Aug 24;10(9):1228. doi: 10.3390/biom10091228. Biomolecules. 2020. PMID: 32846891 Free PMC article.
-
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases.Pharmacol Ther. 2023 Apr;244:108394. doi: 10.1016/j.pharmthera.2023.108394. Epub 2023 Mar 24. Pharmacol Ther. 2023. PMID: 36966972 Free PMC article. Review.
References
-
- Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M. & Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiological reviews 89, 309–380 (2009). - PubMed
-
- Tanimura A. et al.. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 65, 320–327 (2010). - PubMed
-
- Wilson R. I. & Nicoll R. A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588–592 (2001). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases